P1-238Clinical efficacy of mTOR inhibitor for Kaposiform hemangioendotheliomas with Kasabach-Merritt phenomenon
Show all results sharing this subject:
See Kasabach–Merritt syndrome.• Histologically distinct from haemangiomas.• Mortality rate of 24% from coagulopathy and local infiltration.• Treatment as for Haemangiomas with close monitoring of coagulopathy.
• Histologically distinct from haemangiomas.
A-Z of Plastic Surgery »
Plastic and Reconstructive Surgery.
See all related items in Oxford Index »
Search for the text `Kaposiform hemangioendothelioma' anywhere in Oxford Index »
Users without a subscription are not able to see the full content. Please,
or login to access all content.
Forgot your password?